TABLE OF CONTENTS I
LIST OF FIGURES XVII
LIST OF CHARTS XXI
EXECUTIVE SUMMARY 1
EUROPEAN MARKET FOR VASCULAR ACCESS DEVICES AND ACCESSORIES OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 5
MARKET DEVELOPMENTS 6
PROCEDURE NUMBERS 7
MARKETS INCLUDED 8
KEY REPORT UPDATES 11
VERSION HISTORY 12
RESEARCH METHODOLOGY 13
1.1 RESEARCH SCOPE 13
1.2 IDATA’S 9-STEP METHODOLOGY 13
Step 1: Project Initiation & Team Selection 13
Step 2: Prepare Data Systems and Perform Secondary Research 15
Step 3: Preparation for Interviews & Questionnaire Design 16
Step 4: Performing Primary Research 17
Step 5: Research Analysis: Establishing Baseline Estimates 19
Step 6: Market Forecast and Analysis 20
Step 7: Identify Strategic Opportunities 22
Step 8: Final Review and Market Release 23
Step 9: Customer Feedback and Market Monitoring 24
DISEASE OVERVIEW 25
2.1 BASIC ANATOMY 25
2.1.1 Human Vascular System 25
2.2 VASCULAR PATHOLOGY AND DISORDERS 26
2.2.1 Cancer 26
2.2.2 End-Stage Renal Disease 27
2.2.3 Diabetes 29
PRODUCT ASSESSMENT 32
3.1 PRODUCT PORTFOLIOS 32
3.1.1 Implantable Port Devices 32
3.1.1.1 Introduction 32
3.1.1.1.1 Implantable Port Patients 32
3.1.1.1.2 Port Implantation Procedures 33
3.1.1.1.3 Port Infusion 33
3.1.1.1.4 Port Maintenance 34
3.1.1.2 AngioDynamics 34
3.1.1.2.1 BioFlo® 34
3.1.1.2.2 LifePort® 34
3.1.1.2.3 Smart Port® CT 34
3.1.1.2.4 TitanPort® 34
3.1.1.2.5 Triumph-1® 35
3.1.1.2.6 Vortex® 35
3.1.1.2.7 Xcela™ Plus 35
3.1.1.3 B. Braun 35
3.1.1.3.1 Celsite® 35
3.1.1.4 Cook Medical 35
3.1.1.4.1 Vital-Port® 35
3.1.1.5 C.R. Bard 36
3.1.1.5.1 PowerPort® 36
3.1.1.5.2 SlimPort® 36
3.1.1.5.3 X-Port™ 36
3.1.1.5.4 Other Port Offerings 36
3.1.1.6 Medcomp 36
3.1.1.6.1 Dignity® 36
3.1.1.6.2 Pro-Fuse® CT 37
3.1.1.7 PFM Medical 37
3.1.1.7.1 T-Port™ 37
3.1.1.7.2 TitaJet™ 37
3.1.1.7.3 Jet Port® 37
3.1.1.7.4 DualPort 37
3.1.1.8 Smiths Medical 37
3.1.1.8.1 P.A.S. PORT® 37
3.1.1.8.2 PORT-A-CATH® 38
3.1.1.9 Teleflex Medical 38
3.1.1.9.1 Polysite® 38
3.2 REGULATORY ISSUES AND RECALLS 39
3.2.1 November 2015 39
3.2.2 October 2015 39
3.2.3 September 2015 40
3.2.4 August 2015 42
3.2.5 July 2015 43
3.2.6 April 2015 45
3.2.7 March 2015 46
3.2.8 February 2015 47
3.2.9 January 2015 47
3.2.10 December 2014 48
3.2.11 October 2014 49
3.2.12 September 2014 50
3.2.13 May 2014 51
3.2.14 April 2014 51
3.2.15 March 2014 52
3.2.16 January 2014 52
3.2.17 December 2013 53
3.2.18 September 2013 54
3.2.19 August 2013 55
3.2.20 June 2013 55
3.2.21 March 2013 56
3.2.22 February 2013 57
3.2.23 December 2012 57
3.2.24 August 2012 57
3.2.25 June 2012 58
3.2.26 May 2012 59
3.2.27 March 2012 60
3.2.28 February 2012 61
3.2.29 January 2012 61
3.3 CLINICAL TRIALS 65
3.3.1 Implantable Port Devices 66
3.4 PRODUCT PIPELINES 68
3.4.1 Alliance Vascular Devices, LLC 68
3.4.1.1 FreeHand Safety Huber Needle® 68
3.4.2 AngioDynamics 68
3.4.2.1 Celerity™ PICC Tip Confirmation System with Navigation 68
3.4.2.2 Firefly 68
3.4.2.3 BioFlo® PICC Line Extension 69
3.4.2.4 BioFlo® Port Line Extension 69
3.4.2.5 Next Generation BioFlo® PICC 69
3.4.2.6 Next Generation BioFlo® Port 69
3.4.3 Bluegrass Vascular Technologies, Inc. 69
3.4.3.1 Surfacer® Inside-Out™ Access System 69
3.4.4 C.R. Bard 69
3.4.4.1 Chemical-Resistant PICCs 69
3.4.4.2 Novel Advanced Material PICCs 70
3.4.4.3 PowerGlide® Pro Midline 70
3.4.4.4 AccuCath® 70
3.4.4.5 Xenesis™ Acute Hemodialysis Catheter 70
3.4.4.6 Site~Rite® 8 Ultrasound System 70
3.4.5 M. C. Johnson 70
3.4.5.1 PICC Securement Device 70
3.4.6 Nipro Medical 71
3.4.6.1 Shielding Safety Needle 71
3.4.6.2 Safety Syringe 71
3.4.6.3 Safety PIVC 71
3.4.7 Parasol Medical 71
3.4.7.1 Catheter Securement Device 71
3.4.8 PAVmed Inc. 71
3.4.8.1 NextCath™ 71
3.4.9 Phase One Medical 71
3.4.9.1 Goldilocks™ Long Term Hemodialysis Catheter 71
3.4.9.2 Triple-Lumen Symetrex™ Hemodialysis Catheter 72
3.4.10 Prodigy Diabetes Care, LLC. 72
3.4.10.1 Insulin Pen Needles 72
3.4.11 Sharklet Technologies, Inc. 72
3.4.11.1 Sharklet™ Central Venous Catheter 72
3.4.12 Starboard Medical 72
3.4.12.1 Catheter Securement Devices 72
3.4.13 Teleflex Medical 73
3.4.13.1 Arrow® Endurance™ Extended Dwell Peripheral Catheter System 73
3.4.13.2 Tip Confirmation for CVCs, Chronic Hemodialysis Catheters & Ports 73
3.4.14 Vascular Access Technologies, Inc. 73
3.4.14.1 SAFECVAD™ 73
COUNTRY PROFILES 74
4.1 INTRODUCTION 74
4.1.1 Population 74
4.1.2 GDP Per Capita 74
4.1.3 Price Index 74
4.2 GERMANY 75
4.3 FRANCE 76
4.4 UNITED KINGDOM 77
4.5 ITALY 78
4.6 SPAIN 79
4.7 BENELUX 80
4.8 SCANDINAVIA 81
4.9 AUSTRIA 82
4.10 SWITZERLAND 83
4.11 PORTUGAL 84
IMPLANTABLE PORT MARKET 85
5.1 INTRODUCTION 85
5.1.1 Implantable Port Patients 85
5.1.2 Port Implantation Procedures 86
5.1.3 Port Infusion 86
5.1.4 Port Maintenance 87
5.1.5 Power Ports 87
5.2 MARKET OVERVIEW 88
5.3 MARKET ANALYSIS AND FORECAST 92
5.3.1 Total Implantable Port Market 92
5.3.2 Conventional Implantable Port Market 100
5.3.2.1 Single-Lumen Conventional Implantable Port Market 107
5.3.2.2 Double-Lumen Conventional Implantable Port Market 109
5.3.3 Power-Injectable Implantable Port Market 111
5.3.3.1 Single-Lumen Power-Injectable Implantable Port Market 119
5.3.3.2 Double-Lumen Power-Injectable Implantable Port Market 121
5.4 DRIVERS AND LIMITERS 123
5.4.1 Market Drivers 123
5.4.2 Market Limiters 124
5.5 COMPETITIVE MARKET SHARE ANALYSIS 127
ABBREVIATIONS 132
APPENDIX II: COMPANY PRESS RELEASES 134

Chart List
Chart 1 1: Vascular Access Device and Accessories Market by Segment, Europe, 2013 – 2023 2
Chart 1 2: Vascular Access Device and Accessories Market Overview, Europe, 2016 & 2023 2
Chart 4 1: Country Profile, Germany, 2016 75
Chart 4 2: Country Profile, France, 2016 76
Chart 4 3: Country Profile, United Kingdom, 2016 77
Chart 4 4: Country Profile, Italy, 2016 78
Chart 4 5: Country Profile, Spain, 2016 79
Chart 4 6: Country Profile, Benelux, 2016 80
Chart 4 7: Country Profile, Scandinavia, 2016 81
Chart 4 8: Country Profile, Austria, 2016 82
Chart 4 9: Country Profile, Switzerland, 2016 83
Chart 4 10: Country Profile, Portugal, 2016 84
Chart 5 1: Implantable Port Market by Segment, Europe, 2013 – 2023 90
Chart 5 2: Implantable Port Market Breakdown, Europe, 2016 91
Chart 5 3: Implantable Port Market Breakdown, Europe, 2023 91
Chart 5 4: Total Implantable Port Market, Europe, 2013 – 2023 94
Chart 5 5: Conventional Implantable Port Market, Europe, 2013 – 2023 101
Chart 5 6: Single-Lumen Conventional Implantable Port Market, Europe, 2013 – 2023 (€M) 108
Chart 5 7: Double-Lumen Conventional Implantable Port Market, Europe, 2013 – 2023 (€M) 110
Chart 5 8: Power-Injectable Implantable Port Market, Europe, 2013 – 2023 113
Chart 5 9: Leading Competitors, Implantable Port Market, Europe, 2016 131


Figure List
Figure 1 1: Vascular Access Device and Accessories Competitor Market Share Ranking by Segment, Europe, 2016 (1 of 2) 3
Figure 1 2: Vascular Access Device and Accessories Competitor Market Share Ranking by Segment, Europe, 2016 (2 of 2) 3
Figure 1 3: Companies Researched in this Report, Europe, 2016 4
Figure 1 4: Factors Impacting the Vascular Access Device and Accessories Market by Segment, Europe, 2016 5
Figure 1 5: Recent Events in the Vascular Access Device and Accessories Market, Europe, 2013 – 2016 6
Figure 1 6: Vascular Access Procedures Covered, Europe, 2016 7
Figure 1 7: Vascular Access Device and Accessories Markets Covered, Europe, 2016 (1 of 3) 8
Figure 1 8: Vascular Access Device and Accessories Markets Covered, Europe, 2016 (2 of 3) 9
Figure 1 9: Vascular Access Device and Accessories Markets Covered, Europe, 2016 (3 of 3) 10
Figure 1 10: Key Report Updates 11
Figure 1 11: Version History 12
Figure 3 1: Class 2 Device Recall Medtronic 39
Figure 3 2: Class 2 Device Recall Smiths Medical 39
Figure 3 3: Class 2 Device Recall Arrow 40
Figure 3 4: Class 2 Device Recall Arrow 40
Figure 3 5: Class 2 Device Recall Covidien (Medtronic) 41
Figure 3 6: Class 2 Device Recall Arrow 42
Figure 3 7: Class 2 Device Recall Medline 42
Figure 3 8: Class 2 Device Recall Arrow 42
Figure 3 9: Class 2 Device Recall B. Braun 42
Figure 3 10: Class 3 Device Recall Bard Access 43
Figure 3 11: Class 2 Device Recall Covidien (Medtronic) 43
Figure 3 12: Class 2 Device Recall Bard Access 45
Figure 3 13: Class 2 Device Recall Bard Access 45
Figure 3 14: Class 2 Device Recall Medcomp & AngioDynamics 46
Figure 3 15: Class 2 Device Recall Bard Access 46
Figure 3 16: Class 2 Device Recall Arrow 47
Figure 3 17: Class 2 Device Recall Medcomp 47
Figure 3 18: Class 2 Device Recall Arrow 47
Figure 3 19: Class 2 Device Recall Arrow 48
Figure 3 20: Class 2 Device Recall Smiths Medical 48
Figure 3 21: Class 2 Device Recall PFM Medical 48
Figure 3 22: Class 2 Device Recall PFM Medical 48
Figure 3 23: Class 2 Device Recall Becton Dickinson 49
Figure 3 24: Class 2 Device Recall Arrow 49
Figure 3 25: Class 2 Device Recall Arrow 49
Figure 3 26: Class 2 Device Recall Navilyst Medical 49
Figure 3 27: Class 2 Device Recall Argon Medical 50
Figure 3 28: Class 2 Device Recall Arrow 51
Figure 3 29: Class 2 Device Recall Arrow 51
Figure 3 30: Class 2 Device Recall Arrow 52
Figure 3 31: Class 2 Device Recall Bard Access 52
Figure 3 32: Class 2 Device Recall Navilyst Medical 52
Figure 3 33: Class 2 Device Recall Bard Access 53
Figure 3 34: Class 2 Device Recall Smiths Medical 53
Figure 3 35: Class 2 Device Recall B. Braun 53
Figure 3 36: Class 2 Device Recall Smiths Medical 54
Figure 3 37: Class 2 Device Recall Access Scientific 54
Figure 3 38: Class 2 Device Recall Covidien (Medtronic) 54
Figure 3 39: Class 2 Device Recall Arrow 55
Figure 3 40: Class 2 Device Recall Bard Access 55
Figure 3 41: Class 2 Device Recall Becton Dickinson 55
Figure 3 42: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 56
Figure 3 43: Class 2 Device Recall Bard Access 56
Figure 3 44: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 56
Figure 3 45: Class 2 Device Recall Medcomp 57
Figure 3 46: Class 2 Device Recall Becton Dickinson 57
Figure 3 47: Class 3 Device Recall Bard Access 57
Figure 3 48: Class 2 Device Recall Medcomp 58
Figure 3 49: Class 1 Device Recall Arrow 58
Figure 3 50: Class 2 Device Recall Arrow 58
Figure 3 51: Class 2 Device Recall Vygon 58
Figure 3 52: Class 2 Device Recall Covidien (Medtronic) 59
Figure 3 53: Class 2 Device Recall Medcomp 60
Figure 3 54: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 60
Figure 3 55: Class 2 Device Recall Christie Medical Holdings 60
Figure 3 56: Class 3 Recall Bard Access 60
Figure 3 57: Class 2 Device Recall AngioDynamics 61
Figure 3 58: Class 2 Device Recall Becton Dickinson 61
Figure 3 59: Class 2 Device Recall AngioDynamics 61
Figure 3 60: Class 2 Device Recall AngioDynamics 63
Figure 3 61: Class 3 Device Recall AngioDynamics 64
Figure 3 62: Class 2 Device Recall AngioDynamics 64
Figure 3 63: Bone Anchored Port - a Novel Vascular Access for Hemodialysis Treatment 66
Figure 3 64: A Pragmatic Randomized Trial 66
Figure 3 65: Assessment of a Power Injectable vs. a Non-Power Injectable 67
Figure 3 66: Vascular Access in Cancer Patients 67
Figure 3 67: Ultrasound-guided Subclavian Vein Puncture Versus Cephalic Vein Dissection 67
Figure 5 1: Implantable Port Market by Segment, Europe, 2013 – 2023 (€M) 89
Figure 5 2: Implantable Port Market by Segment, Europe, 2013 – 2023 (US$M) 89
Figure 5 3: Total Implantable Port Market, Europe, 2013 – 2023 (€ and US$) 93
Figure 5 4: Units Sold by Country, Total Implantable Port Device Market, Europe, 2013 – 2023 95
Figure 5 5: Average Selling Price by Country, Total Implantable Port Market, Europe, 2013 – 2023 (€) 96
Figure 5 6: Average Selling Price by Country, Total Implantable Port Market, Europe, 2013 – 2023 (US$) 97
Figure 5 7: Market Value by Country, Implantable Port Market, Europe, 2013 – 2023 (€M) 98
Figure 5 8: Market Value by Country, Implantable Port Market, Europe, 2013 – 2023 (US$M) 99
Figure 5 9: Conventional Implantable Port Market, Europe, 2013 – 2023 (€M) 101
Figure 5 10: Units Sold by Country, Conventional Implantable Port Market, Europe, 2013 – 2023 102
Figure 5 11: Average Sales Price by Country, Conventional Implantable Port Market, Europe, 2013 – 2023 (€) 103
Figure 5 12: Average Sales Price by Country, Conventional Implantable Port Market, Europe, 2013 – 2023 (US$) 104
Figure 5 13: Conventional Implantable Port Market, Europe, 2013 – 2023 (€M) 105
Figure 5 14: Conventional Implantable Port Market, Europe, 2013 – 2023 (US$M) 106
Figure 5 15: Single-Lumen Conventional Implantable Port Market, Europe, 2013 – 2023 (€M) 107
Figure 5 16: Double-Lumen Conventional Implantable Port Market, Europe, 2013 – 2023 (€M) 109
Figure 5 17: Power-Injectable Implantable Port Market, Europe, 2013 – 2023 (€M) 112
Figure 5 18: Units Sold by Country, Power-Injectable Implantable Port Market, Europe, 2013 – 2023 114
Figure 5 19: Average Sales Price by Country, Power-Injectable Implantable Port Market, Europe, 2013 – 2023 (€) 115
Figure 5 20: Average Sales Price by Country, Power-Injectable Implantable Port Market, Europe, 2013 – 2023 (US$) 116
Figure 5 21: Power-Injectable Implantable Port Market, Europe, 2013 – 2023 (€M) 117
Figure 5 22: Power-Injectable Implantable Port Market, Europe, 2013 – 2023 (US$M) 118
Figure 5 23: Single-Lumen Power-Injectable Implantable Port Market, Europe, 2013 – 2023 (€M) 119
Chart 5 24: Single-Lumen Power-Injectable Implantable Port Market, Europe, 2013 – 2023 (€M) 120
Figure 5 25: Double-Lumen Power-Injectable Implantable Port Market, Europe, 2013 – 2023 (€M) 121
Chart 5 26: Double-Lumen Power-Injectable Implantable Port Market, Europe, 2013 – 2023 (€M) 122
Figure 5 27: Drivers and Limiters, Implantable Port Market, Europe, 2016 126
Figure 5 28: Leading Competitors by Country, Implantable Port Market, Europe, 2016 130
Figure 7 1: Press Release Summary 134